Ethical Analysis of Withdrawing Total Artificial Heart Support

Erin S. DeMartino, Sara E. Wordingham, John M. Stulak, Barry A. Boilson, Kayla R. Fuechtmann, Nausheen Singh, Daniel P. Sulmasy, Octavio E. Pajaro, Paul Mueller

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives To describe the characteristics of patients who undergo withdrawal of total artificial heart support and to explore the ethical aspects of withdrawing this life-sustaining treatment. Patients and Methods We retrospectively reviewed the medical records of all adult recipients of a total artificial heart at Mayo Clinic from the program's inception in 2007 through June 30, 2015. Management of other life-sustaining therapies, approach to end-of-life decision making, engagement of ethics and palliative care consultation, and causes of death were analyzed. Results Of 47 total artificial heart recipients, 14 patients or their surrogates (30%) requested withdrawal of total artificial heart support. No request was denied by treatment teams. All 14 patients were supported with at least 1 other life-sustaining therapy. Only 1 patient was able to participate in decision making. Conclusion It is widely held to be ethically permissible to withdraw a life-sustaining treatment when the treatment no longer meets the patient's health care–related goals (ie, the burdens outweigh the benefits). These data suggest that some patients, surrogates, physicians, and other care providers believe that this principle extends to the withdrawal of total artificial heart support.

Original languageEnglish (US)
Pages (from-to)719-725
Number of pages7
JournalMayo Clinic Proceedings
Volume92
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Ethical Analysis
Artificial Heart
Decision Making
Therapeutics
Palliative Care
Ethics
Medical Records
Cause of Death
Referral and Consultation
Physicians
Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

DeMartino, E. S., Wordingham, S. E., Stulak, J. M., Boilson, B. A., Fuechtmann, K. R., Singh, N., ... Mueller, P. (2017). Ethical Analysis of Withdrawing Total Artificial Heart Support. Mayo Clinic Proceedings, 92(5), 719-725. https://doi.org/10.1016/j.mayocp.2017.01.021

Ethical Analysis of Withdrawing Total Artificial Heart Support. / DeMartino, Erin S.; Wordingham, Sara E.; Stulak, John M.; Boilson, Barry A.; Fuechtmann, Kayla R.; Singh, Nausheen; Sulmasy, Daniel P.; Pajaro, Octavio E.; Mueller, Paul.

In: Mayo Clinic Proceedings, Vol. 92, No. 5, 01.05.2017, p. 719-725.

Research output: Contribution to journalArticle

DeMartino, ES, Wordingham, SE, Stulak, JM, Boilson, BA, Fuechtmann, KR, Singh, N, Sulmasy, DP, Pajaro, OE & Mueller, P 2017, 'Ethical Analysis of Withdrawing Total Artificial Heart Support', Mayo Clinic Proceedings, vol. 92, no. 5, pp. 719-725. https://doi.org/10.1016/j.mayocp.2017.01.021
DeMartino ES, Wordingham SE, Stulak JM, Boilson BA, Fuechtmann KR, Singh N et al. Ethical Analysis of Withdrawing Total Artificial Heart Support. Mayo Clinic Proceedings. 2017 May 1;92(5):719-725. https://doi.org/10.1016/j.mayocp.2017.01.021
DeMartino, Erin S. ; Wordingham, Sara E. ; Stulak, John M. ; Boilson, Barry A. ; Fuechtmann, Kayla R. ; Singh, Nausheen ; Sulmasy, Daniel P. ; Pajaro, Octavio E. ; Mueller, Paul. / Ethical Analysis of Withdrawing Total Artificial Heart Support. In: Mayo Clinic Proceedings. 2017 ; Vol. 92, No. 5. pp. 719-725.
@article{6bac055d86514399ac8b241f44597693,
title = "Ethical Analysis of Withdrawing Total Artificial Heart Support",
abstract = "Objectives To describe the characteristics of patients who undergo withdrawal of total artificial heart support and to explore the ethical aspects of withdrawing this life-sustaining treatment. Patients and Methods We retrospectively reviewed the medical records of all adult recipients of a total artificial heart at Mayo Clinic from the program's inception in 2007 through June 30, 2015. Management of other life-sustaining therapies, approach to end-of-life decision making, engagement of ethics and palliative care consultation, and causes of death were analyzed. Results Of 47 total artificial heart recipients, 14 patients or their surrogates (30{\%}) requested withdrawal of total artificial heart support. No request was denied by treatment teams. All 14 patients were supported with at least 1 other life-sustaining therapy. Only 1 patient was able to participate in decision making. Conclusion It is widely held to be ethically permissible to withdraw a life-sustaining treatment when the treatment no longer meets the patient's health care–related goals (ie, the burdens outweigh the benefits). These data suggest that some patients, surrogates, physicians, and other care providers believe that this principle extends to the withdrawal of total artificial heart support.",
author = "DeMartino, {Erin S.} and Wordingham, {Sara E.} and Stulak, {John M.} and Boilson, {Barry A.} and Fuechtmann, {Kayla R.} and Nausheen Singh and Sulmasy, {Daniel P.} and Pajaro, {Octavio E.} and Paul Mueller",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.mayocp.2017.01.021",
language = "English (US)",
volume = "92",
pages = "719--725",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "5",

}

TY - JOUR

T1 - Ethical Analysis of Withdrawing Total Artificial Heart Support

AU - DeMartino, Erin S.

AU - Wordingham, Sara E.

AU - Stulak, John M.

AU - Boilson, Barry A.

AU - Fuechtmann, Kayla R.

AU - Singh, Nausheen

AU - Sulmasy, Daniel P.

AU - Pajaro, Octavio E.

AU - Mueller, Paul

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objectives To describe the characteristics of patients who undergo withdrawal of total artificial heart support and to explore the ethical aspects of withdrawing this life-sustaining treatment. Patients and Methods We retrospectively reviewed the medical records of all adult recipients of a total artificial heart at Mayo Clinic from the program's inception in 2007 through June 30, 2015. Management of other life-sustaining therapies, approach to end-of-life decision making, engagement of ethics and palliative care consultation, and causes of death were analyzed. Results Of 47 total artificial heart recipients, 14 patients or their surrogates (30%) requested withdrawal of total artificial heart support. No request was denied by treatment teams. All 14 patients were supported with at least 1 other life-sustaining therapy. Only 1 patient was able to participate in decision making. Conclusion It is widely held to be ethically permissible to withdraw a life-sustaining treatment when the treatment no longer meets the patient's health care–related goals (ie, the burdens outweigh the benefits). These data suggest that some patients, surrogates, physicians, and other care providers believe that this principle extends to the withdrawal of total artificial heart support.

AB - Objectives To describe the characteristics of patients who undergo withdrawal of total artificial heart support and to explore the ethical aspects of withdrawing this life-sustaining treatment. Patients and Methods We retrospectively reviewed the medical records of all adult recipients of a total artificial heart at Mayo Clinic from the program's inception in 2007 through June 30, 2015. Management of other life-sustaining therapies, approach to end-of-life decision making, engagement of ethics and palliative care consultation, and causes of death were analyzed. Results Of 47 total artificial heart recipients, 14 patients or their surrogates (30%) requested withdrawal of total artificial heart support. No request was denied by treatment teams. All 14 patients were supported with at least 1 other life-sustaining therapy. Only 1 patient was able to participate in decision making. Conclusion It is widely held to be ethically permissible to withdraw a life-sustaining treatment when the treatment no longer meets the patient's health care–related goals (ie, the burdens outweigh the benefits). These data suggest that some patients, surrogates, physicians, and other care providers believe that this principle extends to the withdrawal of total artificial heart support.

UR - http://www.scopus.com/inward/record.url?scp=85018376935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018376935&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.01.021

DO - 10.1016/j.mayocp.2017.01.021

M3 - Article

C2 - 28473036

AN - SCOPUS:85018376935

VL - 92

SP - 719

EP - 725

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 5

ER -